Featured Article: Naloxone, an Opioid Overdose Drug (September 21st, 2023)
<p><em>Congressional Communities is featuring one Congressional Research Service (CRS) article per day in effort to share with our readers the wealth of information that the CRS makes readily available.</em></p>
<p>Today’s featured CRS article, “<strong>Naloxone for Opioid Overdose: Considerations for Congress</strong>,” discusses several topics related to Naloxone, which is a medication that, when administered in a timely manner, can reverse opioid overdoses.</p>
<p>The report begins by explaining what Naloxone is, and describing, medically, how it reverses overdoses. Then, the report goes on to lay out what current federal regulations exist for Naloxone, as well as what current forms exist that it can be administered in. Issues of interest for Congress regarding Naloxone are also covered, such as increasing accessibility to Naloxone, the cost of Naloxone, and more.</p>
<p><a href="https://medium.com/@congresscom/featured-article-naloxone-an-opioid-overdose-drug-september-21st-2023-e393377406c2"><strong>Read More</strong></a></p>